======= SALL2 ======= == Gene Information == * **Official Symbol**: SALL2 * **Official Name**: spalt like transcription factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6297|6297]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y467|Q9Y467]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SALL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SALL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602219|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein containing multiple zinc finger domains. The encoded protein functions in optical fissure closure during development of the eye in the embryo. Mutations in this gene are associated with ocular coloboma. [provided by RefSeq, Jul 2016]. * **UniProt Summary**: Probable transcription factor that plays a role in eye development before, during, and after optic fissure closure. {ECO:0000269|PubMed:24412933}. No Pfam Domain information is available for this gene. |neural tube development| |protein-containing complex binding| |RNA polymerase II regulatory region sequence-specific DNA binding| |eye development| |visual system development| |sensory system development| |DNA-binding transcription activator activity, RNA polymerase II-specific| |sensory organ development| |chordate embryonic development| |embryo development ending in birth or egg hatching| |tube development| |negative regulation of transcription by RNA polymerase II| |embryo development| |epithelium development| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.77| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.46| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4796 * **Expression level (log2 read counts)**: 3.52 {{:chemogenomics:nalm6 dist.png?nolink |}}